Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$1.0 - $6.12 $50,622 - $309,806
-50,622 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$6.03 - $11.24 $305,250 - $568,991
50,622 New
50,622 $311,000
Q2 2018

Aug 14, 2018

SELL
$8.91 - $14.54 $602,405 - $983,049
-67,610 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$5.57 - $14.28 $376,587 - $965,470
67,610 New
67,610 $0

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $69.8M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.